FDA.reportPublic FDA data

dupilumab 100 MG in 0.67 ML Prefilled Syringe

RxCUI
2583634
RxNorm name
dupilumab 100 MG in 0.67 ML Prefilled Syringe
Display name
dupilumab 100 MG in 0.67 ML Prefilled Syringe
Full name
dupilumab 100 MG in 0.67 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761055Dupixentdupilumab351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
595f437d-2729-40bb-9c62-c8ece1f82780dupilumab 100 MG in 0.67 ML Prefilled Syringe [PSN] · 0.67 ML dupilumab 150 MG/ML Prefilled Syringe [SCD]256These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT ® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 201720260422